SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-096331
Filing Date
2024-08-13
Accepted
2024-08-13 17:01:13
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 evoke_s-3_8-13-2024.htm S-3 548645
2 EX-5.1 evok-ex5_1.htm EX-5.1 36932
3 EX-23.1 evok-ex23_1.htm EX-23.1 3996
4 EX-FILING FEES evok-exfiling_fees.htm EX-FILING FEES 49918
5 GRAPHIC img17980809_0.jpg GRAPHIC 19530
6 GRAPHIC img17980809_1.jpg GRAPHIC 27825
7 GRAPHIC img143151495_0.jpg GRAPHIC 58631
  Complete submission text file 0000950170-24-096331.txt   786854
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281527 | Film No.: 241202703
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)